| Agenda (PDF) |
| Day 1 - Thursday, April 15, 2004 - Laying the Landscape |
| 8:00 - 8:30 a.m. |
Registration and Continental breakfast |
| 8:30 - 8:40 a.m. |
Welcome from the National Cancer Institute |
| 8:40 - 9:00 a.m. |
Charge to participants
Ronald Glaser, Ph.D. and Soldano Ferrone, M.D., Ph.D.
Meeting Co-Chairs |
| 9:00 - 9:45 a.m. |
"Psychoneuroimmunology: Relevance for Cancer"
Janice Kiecolt-Glaser, Ph.D. |
| 9:45 - 10:00 a.m. |
Discussion |
| 10:00 - 10:15 a.m. |
Break |
| 10:15 - 11:00 a.m. |
“Relationships Between Psychoneuroimmunology and Cancer”
Ronald Herberman, M.D. |
| 11:00 - 11:15 a.m. |
Discussion |
| 11:15 - 11:45 p.m. |
"The Seed and Soil of Cancer Metastasis"
Anil Sood, M.D. |
| 11:45 - 12:15 a.m. |
"Developing Immunotherapy for Pediatric Sarcomas: Progress and Challenges"
Crystal MacKall, M.D. |
| 12:15 - 1:30 p.m. |
Lunch |
| 1:30 - 2:05 p.m. |
"In vivo NK Cell Function: Regulation of and by NK Cells"
John Ortaldo, Ph.D. |
| 2:05 - 2:35 p.m. |
"Biobehavioral-Immune Interactions in Ovarian Cancer: Research
Models and Future Directions"
Susan Lutgendorf, Ph.D. |
| 2:35 - 3:05 p.m. |
"Stress and Immunoresponsive Skin Cancer"
Firdaus Dhabhar, Ph.D. |
| 3:05 - 3:20 p.m. |
Break |
| 3:20 - 3:50 p.m. |
"Neuroimmunology, Tumor Immunology, and Immunotherapy: Reciprocal Implications in Controlling Cancer Progression"
Shamgar Ben-Eliyahu, Ph.D. |
| 3:50 - 4:20 p.m. |
"Feeling and Healing: Stress, Diurnal Cortisol, and Cancer Progression"
David Spiegel, M.D. |
| 4:20 - 4:45 p.m. |
Wrap-up, charge for Day 2, and adjournment for the day |
| |
| Day 2 - Friday, April 16, 2004 - Cultivating the Landscape Through Discussion |
| 8:00 - 8:30 a.m. |
Continental breakfast |
| 8:30 - 8:45 a.m. |
Setting the Stage for Discussion |
| 8:45 - 9:45 a.m. |
Discussion Session I: Plausible Tumor Models |
| 9:45 - 10:00 a.m. |
Break |
| 10:00 - 11:00 a.m. |
Discussion Session II: Methodological Advancements in Immunological Monitoring and Tumor Immunology Methods |
| 11:00 - 11:15 a.m. |
Break |
| 11:15 - 12:15 p.m. |
Discussion Session III: Clinical Implications of the Integration Between PNI and Tumor Immunology |
| 12:15 - 1:30 p.m. |
Lunch |
| 1:35 - 2:35 p.m. |
Discussion Session IV: Advancing Transdisciplinary Approaches in Cancer Prevention and Control: Perspectives From PNI and Tumor Immunology |
| 2:35 - 3:00 p.m. |
Wrap-up and adjournment |